QuantLogix's 5-factor engine currently reads Regeneron Pharmaceuticals Inc (REGN) as a neutral at 47/100 — a mixed setup. Fundamental is the strongest leg at 63/100, while options lags at 42/100. In backtesting, 42% of 50 comparable historical setups moved higher within five trading days. REGN trades in the Pharmaceutical Preparations sector with a $64.1B market cap.

Live 5-factor quant signal — technical, momentum, fundamental, options, and microstructure — recomputed every few minutes. Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. See the verified track record → · Browse all signal scorecards →